Latest ReleaseLatest ReleaseThe Squeeze Tube Packaging Market, estimated at USD 8.92 Bn in 2025, is expected to exhibit a CAGR of 6.2% and reach USD 13.60 Bn by 2032. The packaging industry is evolving rapidly, driven by sustainability, innovation, and rising demand across food & beverages, healthcare, e-commerce, and personal care. With increasing focus on eco-friendly mate…
The Osseointegration Implants Market, estimated at USD 9.39 Bn in 2025, is expected to exhibit a CAGR of 8.3% and reach USD 16.42 Bn by 2032. The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancement…
The Nuclear Imaging Equipment Market, estimated at USD 3.57 Bn in 2025, is expected to exhibit a CAGR of 5.1% and reach USD 5.06 Bn by 2032. The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements…
The Biobanking Equipment Market, estimated at USD 3.7 Bn in 2025, is expected to exhibit a CAGR of 11.4% and reach USD 7.88 Bn by 2032. The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in d…
Bangkok, Thailand – September 2025: Coherent Market Insights (CMI) announced its participation as the Official Knowledge Partner at Vitafoods Asia 2025. The event took place from September 17–19, 2025, at the Queen Sirikit National Convention Center (QSNCC), Bangkok, Thailand. CMI's presence on the main stage at Vitafoods Asia 2025 high…
India / Global - 2025 - Coherent Market Insights (CMI) was honored to serve as Research Partner for the ET NOW Best Tech Brands 2025, a national platform recognizing India’s most credible, innovative, and high-performing technology brands across enterprise, consumer, and emerging technology domains. As an AVP – Research & Consultin…
The Ornithine Transcarbamylase (OTC) Deficiency Treatment Market, estimated at USD 880.3 Mn in 2025, is expected to exhibit a CAGR of 4.25% and reach USD 1,178.0 Mn by 2032. The market growth is driven by increasing demand for innovative and effective drugs across diverse therapeutic areas. Advances in drug discovery, biopharmaceuticals, and digit…
The Natural Sweeteners Market, estimated at USD 3.84 Bn in 2025, is expected to exhibit a CAGR of 3.82% and reach USD 4.99 Bn by 2032. The market outlook remains positive, driven by growing demand for healthy, natural, and sustainable food ingredients across diverse food and beverage categories. Advances in processing, sourcing, and product innova…
The Genetic Chronic Obstructive Pulmonary Disease (COPD) Market, estimated at USD 615.5 Mn in 2025, is expected to exhibit a CAGR of 3.2% and reach USD 767.3 Mn by 2032. The market growth is driven by increasing demand for innovative and effective drugs across diverse therapeutic areas. Advances in drug discovery, biopharmaceuticals, and digital t…
The Clostridioides Difficile Infection Treatment Market,, estimated at USD 1,024.9 Mn in 2025, is expected to exhibit a CAGR of 7.13% and reach USD 1,659.8 Mn by 2032. The market growth is driven by increasing demand for innovative and effective drugs across diverse therapeutic areas. Advances in drug discovery, biopharmaceuticals, and digital tec…
The Neurofeedback Market, estimated at USD 1,444.6 Mn in 2025, is expected to exhibit a CAGR of 7.33% and reach USD 2,370.3 Mn by 2032. The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in d…
The Tamiflu (Oseltamivir Phosphate) Market, estimated at US$ 889.2 Mn in 2025,001.6, is expected to exhibit a CAGR of 1.2% and reach US$ 978.6 Mn by 2032. The market growth is driven by increasing demand for innovative and effective drugs across diverse therapeutic areas. Advances in drug discovery, biopharmaceuticals, and digital technologie…
The Heparin Calcium Market, estimated at USD 1,485.0 Mn in 2025, is expected to exhibit a CAGR of 2.7% and reach USD 1,789.4 Mn by 2032. The market growth is driven by increasing demand for innovative and effective drugs across diverse therapeutic areas. Advances in drug discovery, biopharmaceuticals, and digital technologies are improving treatme…
The Veterinary Excipients Market, estimated at USD 300.7 Mn in 2025, is expected to exhibit a CAGR of 7.5% and reach USD 498.9 Mn by 2032. The market growth is driven by increasing demand for innovative and effective drugs across diverse therapeutic areas. Advances in drug discovery, biopharmaceuticals, and digital technologies are improving treat…
The Anticonvulsant Drugs Market, estimated at USD 7,213.9 Mn in 2025, is expected to exhibit a CAGR of 2.2% and reach USD 8,400.9 Mn by 2032. The market growth is driven by increasing demand for innovative and effective drugs across diverse therapeutic areas. Advances in drug discovery, biopharmaceuticals, and digital technologies are improving tr…
The Betamethasone Acetate Market, estimated at USD 484.6 Mn in 2025, is expected to exhibit a CAGR of 4.8% and reach USD 672.8 Mn by 2032. The market growth is driven by increasing demand for innovative and effective drugs across diverse therapeutic areas. Advances in drug discovery, biopharmaceuticals, and digital technologies are improving treat…
The Diphtheria Vaccine Market, estimated at USD 6,047.7 Mn in 2025, is expected to exhibit a CAGR of 5.86% and reach USD 9,009.8 Mn by 2032. The market growth is driven by increasing demand for innovative and effective drugs across diverse therapeutic areas. Advances in drug discovery, biopharmaceuticals, and digital technologies are improving tre…
The Postmenopausal Osteoporosis Market, estimated at USD 5,175.1 Mn in 2025, is expected to exhibit a CAGR of 4.4% and reach USD 6,995.6 Mn by 2032. The market growth is driven by increasing demand for innovative and effective drugs across diverse therapeutic areas. Advances in drug discovery, biopharmaceuticals, and digital technologies are impro…